The treatment landscape for multiple myeloma is evolving rapidly, with novel therapies offering renewed hope for patients ...

football specials betting Erlotinib + ramucirumab approved for first-line treatment of NSCLC, the era of EGFR-TKI monotherapy is coming to an end Jiangsu Wuzhong Esomeprazole Sodium for Injection ...

Isatuximab is under clinical development by Sanofi and currently in Phase II for Metastatic Colorectal Cancer.

Natural killer (NK) cells are the human body’s first line of defense against cancer and infections but tend to get knocked down by treatment with anti-CD38 antibodies. This is because NK cells ...

Adding a business line to your cell phone is useful when you want to keep your business calls separate from your personal calls — and it’s a very simple process. Read on to learn why you should get a ...

Dec. 18, 2024 — Scientists have generated human stem cell models which contain notochord -- a tissue in the developing embryo that acts like a navigation system, directing cells where to build ...

Selinexor is under clinical development by Karyopharm Therapeutics and currently in Phase II for Follicular Lymphoma.

Patients had a median of three prior lines of therapy ... with ISB 2001 leading the charge. This T-cell engager simultaneously targets BCMA, CD38, and CD3, enhancing tumor-specific cytotoxicity ...

MitoThrive is an organic supplement designed to address the root cause that is responsible for aging and low energy le ...

Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.